These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10064000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D, Szlam F, Molinaro RJ, Escobar MA, Levy JH, Tanaka KA.
    Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
    [Abstract] [Full Text] [Related]

  • 4. Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa.
    Eichinger S, Lubsczyk B, Kollars M, Traby L, Zwiauer K, Gleiss A, Quehenberger P, Kyrle PA.
    Eur J Clin Invest; 2009 Aug; 39(8):707-13. PubMed ID: 19490067
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
    Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG.
    Blood; 2002 Feb 01; 99(3):923-30. PubMed ID: 11806995
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y, Loyer F.
    J Lab Clin Med; 1993 Mar 01; 121(3):444-52. PubMed ID: 8445292
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP).
    Zollner S, Schuermann D, Raquet E, Mueller-Cohrs J, Weimer T, Pragst I, Dickneite G, Schulte S.
    J Thromb Haemost; 2014 Feb 01; 12(2):220-8. PubMed ID: 24641308
    [Abstract] [Full Text] [Related]

  • 9. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ, Novotny WF, Wun TC.
    Thromb Res; 1991 Oct 15; 64(2):213-22. PubMed ID: 1811340
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B.
    Hansson KM, Gustafsson D, Skärby T, Frison L, Berntorp E.
    J Thromb Haemost; 2015 Jul 15; 13(7):1293-300. PubMed ID: 25944555
    [Abstract] [Full Text] [Related]

  • 14. Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition.
    Li R, Panckeri KA, Fogarty PF, Diamond SL.
    Haemophilia; 2015 Mar 15; 21(2):266-274. PubMed ID: 25311576
    [Abstract] [Full Text] [Related]

  • 15. Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium.
    Mauser-Bunschoten EP, de Goede-Bolder A, Wielenga JJ, Levi M, Peerlinck K.
    Neth J Med; 1998 Dec 15; 53(6):249-55. PubMed ID: 9883002
    [Abstract] [Full Text] [Related]

  • 16. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
    Campbell RA, Fischer TH, Wolberg AS.
    Br J Haematol; 2007 Jul 15; 138(1):82-93. PubMed ID: 17555451
    [Abstract] [Full Text] [Related]

  • 17. Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.
    Parmar N, Berry LR, Paredes N, Chan AK.
    Clin Lab; 2005 Jul 15; 51(3-4):157-66. PubMed ID: 15819171
    [Abstract] [Full Text] [Related]

  • 18. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.
    Broze GJ, Higuchi DA.
    Blood; 1996 Nov 15; 88(10):3815-23. PubMed ID: 8916945
    [Abstract] [Full Text] [Related]

  • 19. Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.
    Livnat T, Martinowitz U, Zivelin A, Seligsohn U.
    Haemophilia; 2008 Jul 15; 14(4):782-6. PubMed ID: 18371162
    [Abstract] [Full Text] [Related]

  • 20. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.
    Lindahl TL, Wallstedt M, Gustafsson KM, Persson E, Hillarp A.
    Thromb Res; 2015 Mar 15; 135(3):544-7. PubMed ID: 25596769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.